Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Graefes Arch Clin Exp Ophthalmol. 2016 Mar 12;254(5):923–928. doi: 10.1007/s00417-016-3312-3

Table 3.

Anti-glaucoma therapy in the patients who developed ocular hypertension and glaucoma

Disease Treatment No. of Patients (%)
Ocular Hypertension (N=33) Topical anti-glaucoma eye drops 7 (21%)
Topical anti-glaucoma eye drops + selective laser trabeculoplasty 2 (6%)
Glaucoma (N= 1) Topical anti-glaucoma eye drops + glaucoma valve surgery 1 (100%)
HHS Vulnerability Disclosure